Biopredic International NoSpin HepaRG cells, or equal
Closed Solicitation Posted
- Solicitation number
- 75F40124Q123012
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, Food and Drug Administration, Office of Acquisition and Grant Services is seeking to procure Biopredic International NoSpin HepaRG cells, or equal, to conduct research on nitrosamines and nitrosamine drug substance-related impurities. The key requirements include the cells being fully differentiated, cryopreserved, with 8 million cells per vial and over 90% viability. The initial purchase is for 30 units, with options for 30 additional units per year in the following two periods. The solicitation is being issued as a full and open competition, with the award to be made to the lowest priced, technically acceptable responsible offeror based on the evaluation criteria specified in FAR Clause 52.212-2.
There are no set-aside designations for this requirement. The agency has not provided any information about potential incumbents or current contractors. The solicitation does not specify an award value or budget range, but the quantities indicate this may be a multi-year requirement. The place of performance is not specified, but the cells will be used at the FDA's National Center for Toxicological Research.
Notice text
2 versions
Update #2 · Latest ·
UPDATE on 06/14/2024: See attached amendment to the solicitation which requires only one option for the period between 10/01/2024-12/31/2024. The 2nd option has been removed from this requirement.
See attached Request for quote for Biopredic International NoSpin HepaRG cells, or equal.
Pay particular attention to the list of requirements (page 2), plus FARclause 52.212-1 "Instructions to Offerors-Commercial Products and Commercial Services" to ensure your submission is responsive to thesolicitation. Also note FAR Clause 52.212-2 "Evaluation-Commercial Products and Commercial Services" to understand how the government will evaluate quotes.
Update #1 ·
See attached Request for quote for Biopredic International NoSpin HepaRG cells, or equal.
Pay particular attention to the list of requirements (page 2), plus FARclause 52.212-1 "Instructions to Offerors-Commercial Products and Commercial Services" to ensure your submission is responsive to thesolicitation. Also note FAR Clause 52.212-2 "Evaluation-Commercial Products and Commercial Services" to understand how the government will evaluate quotes.
Files
| File | Type | Posted |
|---|---|---|
| 75F40124Q123012-A00001.pdf | ||
| 75F40124Q123012.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| NoSpin HepaRG cells (Biopredic International, or equal) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity